Abstract
The purpose of the present study was to evaluate the ability of the tumour marker carcinoembryonic antigen (CEA) in combination with cancer antigen 125 (CA-125) to differentiate between malignant ovarian and malignant non-ovarian disease.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Danish Medical Bulletin |
| Vol/bind | 58 |
| Udgave nummer | 11 |
| Sider (fra-til) | A4331 |
| ISSN | 0907-8916 |
| Status | Udgivet - 2011 |
Fingeraftryk
Dyk ned i forskningsemnerne om 'Combination of cancer antigen 125 and carcinoembryonic antigen can improve ovarian cancer diagnosis'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS